National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 271334

History of Changes from the VAERS Wayback Machine

First Appeared on 12/31/2007

271334
VAERS Form:
Age:12.0
Gender:Female
Location:Arizona
Vaccinated:2007-01-23
Onset:2007-01-24
Submitted:2007-01-26
Entered:2007-01-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 1209F / 1 RA / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1424F / 0 GM / IM
MNQ: MENINGOCOCCAL (MENACTRA) / AVENTIS PASTEUR U2002AC / 0 GM / IM
TDAP: TDAP (ADACEL) / AVENTIS PASTEUR C2689AA / 0 LA / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 1144F / 1 LA / SC

Administered by: Private      Purchased by: Unknown
Symptoms: Injection site erythema, Injection site inflammation, Injection site irritation, Injection site vesicles

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type':

Write-up:Gardasil was given in office. Pt. reported only some irritation at site following the administration of vaccine. The following day she developed local erythema and sm. blister. She was seen again in the office on 1/25/07. Superficial blister/inflammation"of approx. 0.5 x 1.5cm was noted. No cellulitis noted. Area was lt. pink in color. Advised pt. to keep area clean and dry, apply antibiotic oint. if desired. Only local treatment needed. No further treatment anticipated.


Changed on 12/8/2009

271334 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:Arizona
Vaccinated:2007-01-23
Onset:2007-01-24
Submitted:2007-01-26
Entered:2007-01-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 1209F / 1 RA / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1424F / 0 GM / IM
MNQ: MENINGOCOCCAL (MENACTRA) / AVENTIS PASTEUR U2002AC / 0 GM / IM
TDAP: TDAP (ADACEL) / AVENTIS PASTEUR C2689AA / 0 LA / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 1144F / 1 LA / SC

Administered by: Private      Purchased by: Unknown Private
Symptoms: Injection site erythema, Injection site inflammation, Injection site irritation, Injection site vesicles

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type':

Write-up:Gardasil was given in office. Pt. reported only some irritation at site following the administration of vaccine. The following day she developed local erythema and sm. blister. She was seen again in the office on 1/25/07. Superficial blister/inflammation"of blister/inflammation of approx. 0.5 x 1.5cm was noted. No cellulitis noted. Area was lt. pink in color. Advised pt. to keep area clean and dry, apply antibiotic oint. if desired. Only local treatment needed. No further treatment anticipated.


Changed on 4/7/2010

271334 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:Arizona
Vaccinated:2007-01-23
Onset:2007-01-24
Submitted:2007-01-26
Entered:2007-01-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 1209F / 1 RA / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1424F / 0 GM / IM
MNQ: MENINGOCOCCAL (MENACTRA) MENINGOCOCCAL CONJUGATE (MENACTRA) / AVENTIS PASTEUR U2002AC / 0 GM / IM
TDAP: TDAP (ADACEL) / AVENTIS PASTEUR C2689AA / 0 LA / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 1144F / 1 LA / SC

Administered by: Private      Purchased by: Private
Symptoms: Injection site erythema, Injection site inflammation, Injection site irritation, Injection site vesicles

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type':

Write-up:Gardasil was given in office. Pt. reported only some irritation at site following the administration of vaccine. The following day she developed local erythema and sm. blister. She was seen again in the office on 1/25/07. Superficial blister/inflammation of approx. 0.5 x 1.5cm was noted. No cellulitis noted. Area was lt. pink in color. Advised pt. to keep area clean and dry, apply antibiotic oint. if desired. Only local treatment needed. No further treatment anticipated.


Changed on 5/14/2017

271334 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:Arizona
Vaccinated:2007-01-23
Onset:2007-01-24
Submitted:2007-01-26
Entered:2007-01-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 1209F / 1 RA / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1424F / 0 GM / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / AVENTIS PASTEUR SANOFI PASTEUR U2002AC / 0 GM / IM
TDAP: TDAP (ADACEL) / AVENTIS PASTEUR SANOFI PASTEUR C2689AA / 0 LA / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 1144F / 1 LA / SC

Administered by: Private      Purchased by: Private
Symptoms: Injection site erythema, Injection site inflammation, Injection site irritation, Injection site vesicles

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type':

Write-up:Gardasil was given in office. Pt. reported only some irritation at site following the administration of vaccine. The following day she developed local erythema and sm. blister. She was seen again in the office on 1/25/07. Superficial blister/inflammation of approx. 0.5 x 1.5cm was noted. No cellulitis noted. Area was lt. pink in color. Advised pt. to keep area clean and dry, apply antibiotic oint. if desired. Only local treatment needed. No further treatment anticipated.


Changed on 9/14/2017

271334 Before After
VAERS Form:(blank) 1
Age:12.0
Gender:Female
Location:Arizona
Vaccinated:2007-01-23
Onset:2007-01-24
Submitted:2007-01-26
Entered:2007-01-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 1209F / 1 2 RA / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1424F / 0 1 GM / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U2002AC / 0 1 GM / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR C2689AA / 0 1 LA / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 1144F / 1 2 LA / SC

Administered by: Private      Purchased by: Private
Symptoms: Injection site erythema, Injection site inflammation, Injection site irritation, Injection site vesicles

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type':

Write-up:Gardasil was given in office. Pt. reported only some irritation at site following the administration of vaccine. The following day she developed local erythema and sm. blister. She was seen again in the office on 1/25/07. Superficial blister/inflammation of approx. 0.5 x 1.5cm was noted. No cellulitis noted. Area was lt. pink in color. Advised pt. to keep area clean and dry, apply antibiotic oint. if desired. Only local treatment needed. No further treatment anticipated.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=271334&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166